Advertisement
Advertisement

SLN

SLN logo

Silence Therapeutics Plc - ADR

4.96
USD
Sponsored
-0.04
-0.90%
Jan 29, 15:59 UTC -5
Closed
exchange

After-Market

4.98

+0.02
+0.30%

SLN Earnings Reports

Positive Surprise Ratio

No Data Available for SLN

0%

Next Report

Date of Next Report
Feb 27, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
--
Implied change from Q3 25 (Revenue/ EPS)
--
/
--
Implied change from Q4 24 (Revenue/ EPS)
--
/
--

Silence Therapeutics Plc - ADR earnings per share and revenue

On Nov 06, 2025, SLN reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q3 2025, Silence Therapeutics Plc - ADR reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Feb 27, 2026.
Based on -- analysts, Silence Therapeutics Plc - ADR is expected to report EPS of -- and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement